This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02893/identifier/pubchem-substance/
n5http://linked.opendata.cz/resource/drugbank/drug/DB02893/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02893/identifier/chebi/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB02893/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02893/identifier/kegg-compound/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02893/identifier/pubchem-compound/

Statements

Subject Item
n2:DB02893
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB02893 n12:DB02893
dcterms:title
D-Methionine
adms:identifier
n4:84815 n5:DB02893 n8:C00855 n13:46505884 n14:16867 n15:MED
n6:synthesisReference
Maria-Regina Kula, Matthias Kittelmann, "Method of using N-acetyl-2,3-Didehydroleucine acylase for the preparation of D- or L-tryptophyl glycine, D- or L-tryptophyl-D-methionine or L-tryptophyl-D-cysteine." U.S. Patent US5212069, issued July, 1992.
n6:IUPAC-Name
n7:271B62A4-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B62AA-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B62A9-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B62A6-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B62A7-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B62A8-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B62A2-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B62A3-363D-11E5-9242-09173F13E4C5 n7:271B62A0-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B62A1-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B62B0-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B62B1-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B62AB-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B62AC-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B62AE-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B62AD-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B62AF-363D-11E5-9242-09173F13E4C5
n6:casRegistryNumber
348-67-4
n6:Bioavailability
n7:271B62B6-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B62B8-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B62B9-363D-11E5-9242-09173F13E4C5
n6:Melting-Point
n7:271B62BA-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B62B5-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B62B4-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B62B7-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B62A5-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B62B2-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B62B3-363D-11E5-9242-09173F13E4C5